Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignancies associated with the immunocompromised state.

K Katariya1, R J Thurer

  • 1Thoracic Surgery Section, University of Miami School of Medicine, Florida, USA.

Chest Surgery Clinics of North America
|March 18, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduction of postoperative hypothermia with a new warming device: a prospective randomized study in off-pump coronary artery surgery.

The Journal of cardiovascular surgery·2009
Same author

Sirolimus and tacrolimus in clinical cardiac transplantation.

Transplantation proceedings·2002
Same author

Cryotherapy in early lung cancer.

Chest·2001
Same author

Thoracic malignancies associated with AIDS.

Seminars in thoracic and cardiovascular surgery·2000
Same author

Oral amiodarone reduces incidence of postoperative atrial fibrillation.

The Annals of thoracic surgery·1999
Same author

Surgical management of empyema.

Clinics in chest medicine·1998
Same journal

New treatment modalities for end-stage emphysema.

Chest surgery clinics of North America·2003
Same journal

Cost effectiveness of lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Results of lung volume reduction surgery for emphysema.

Chest surgery clinics of North America·2003
Same journal

Complications after lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Operative techniques for lung volume reduction surgery.

Chest surgery clinics of North America·2003
Same journal

Patient selection for lung volume reduction surgery.

Chest surgery clinics of North America·2003
See all related articles

Immunocompromised patients face a higher risk of aggressive neoplastic diseases, often linked to viral infections or immunosuppressive drugs. These cancers appear earlier and have a worse prognosis, even with treatment.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Neoplastic diseases are more prevalent in immunocompromised individuals compared to the general population.
  • Tumors in these patients tend to manifest at an earlier age and exhibit more aggressive behavior.

Purpose of the Study:

  • To highlight the increased incidence and aggressive nature of neoplastic diseases in immunocompromised patients.
  • To underscore the poor prognosis associated with these cancers despite therapeutic interventions.

Main Methods:

  • Review of existing literature on neoplastic diseases in immunocompromised populations.
  • Analysis of factors contributing to immunodeficiency, including viral infections and immunosuppressive therapies.
  • Comparison of tumor behavior and patient outcomes between immunocompromised and immunocompetent individuals.

Related Experiment Videos

Main Results:

  • Immunocompromised patients exhibit a higher frequency of neoplastic diseases.
  • Onset of these tumors is earlier, and their clinical behavior is more aggressive.
  • Viral infections and immunosuppressive drugs are identified as significant contributing factors to immunodeficiency-related cancers.

Conclusions:

  • Neoplastic diseases pose a significant threat to immunocompromised patients, characterized by early onset and aggressive progression.
  • The underlying causes, including viral infections and immunosuppression, necessitate targeted management strategies.
  • Despite advancements in therapy, the prognosis for these patients remains unfavorable compared to their immunocompetent counterparts.